CELL/TISSUE CULTURE SUPPLIES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Cell/Tissue Culture Supplies in US$ Million by the following Product Segments: Media, Sera, and Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 131 companies including many key and niche players such as Affymetrix, Inc., AMRESCO, Inc., BD Biosciences, Cell Culture Technologies, LLC, Cell Essentials, Inc., Irvine Scientific, Life Technologies Corporation, Lonza Biologics Plc, Mediatech, Inc., Millipore Corporation, Medi-Cult A/S, MP Biomedicals, PerBio Science AB, PromoCell GmbH, Sera Laboratories International, Sigma-Aldrich Corporation, SAFC Biosciences, and Vitrolife AB. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-3538
Price : $4500
Companies : 131
Pages : 621
Date : October 2010
Market Data Tables : 51

Complimentary Copy of Study Findings:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2
Data Interpretation & Reporting Level.......2
  
   Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
Cell/Tissue Culture Media, Sera and Reagents.......3
  
   Outlook ........5
Biopharmaceutical Drugs Fuel Cell Culture Market........5
1$100
   Market Scenario........6
Industrial vs. Academic........6
Biotechnology Sector – Affected by Collapse of Capital Market........6
Global Market Analysis........6
1$100
   Market Structure........7
1$100
   US Government’s Policies to Boost Cell Culture Market........8
Surging Demand for Cell Culture Products........8
Stem Cells and Vaccines – Key Drivers........8
Growing Acceptance for Hi-Veg Culture Media........8
1$100
   Fed-Batch Cultures – a Big Hit with Large-Scale Bioprocessors........9
Changing Trend Towards Serum-Free Media........9
Proteomics and Pharmacokinetics to Drive Market Growth........9
1$100
   Bioresearch and Cell Culture in Protein-Based Drug Development........101$100
   CHO, Hybridomas and Mabs Dominate Mammalian Cell Culture........11
Sluggish Fetal Bovine Serum Market........11
Specialty Media Demand on Rise........11
1$100
   Emerging Alternatives to Conventional Serum Supplemented Media........12
Growth of Defined Media........12
Regulations Prompt Change in Trends........12
Media Optimization........12
Cell-Line Engineering Vs. Cell Culture Media........12
1$100
   Other Trends........13
Underlying Threat to Cell Culture Industry........13
Manufacture-on-Demand: Gaining Momentum........13
Move Towards Contract Manufacturing........13
1$100
   Factors Impacting Growth........14
Business Models Driving the Need for Contract Manufacturing........14
Trends in Contract Manufacturing........14
Target Sectors for Contract Manufacturers........14
2$200
   End-Use Applications........16
Cell Therapy........16
Growing by Leaps and Bounds........16
1$100
   Cell Therapy Applications........17
Key Factors Affecting the Cell Therapy Market........17
Future Trends........17
Related Market Sectors........17
Progenitor Cell Therapy........17
1$100
   Stem Cell Therapy........181$100
   Other Related Technologies........19
Somatic Cell Nuclear Transfer (SCNT)........19
Tissue Engineering........19
End Use Industries........19
1$100
   Introduction........20
History........20
4$300
   Plant Cell and Tissue Culture (PCTC)........243$300
   Cell/Tissue Culture Media, Sera and Reagents........27
Classical Media........27
1$100
   Specialty Media........28
Serum ........28
Fetal Bovine Serum........28
Serum-Free Media........28
1$100
   Cell Culture Reagents........29
Role of Tissue Culture in the Growth of Cell Types........29
Equipment........29
Storage and Preservation........29
1$100
   Maintenance........30
Growth Pattern........30
Harvesting........30
1$100
   Media and Growth Requirements........31
Physiological Parameters........31
Medium Requirements (Often Empirical)........31
Feeding........31
Safety Precautions........31
1$100
   Methods of Tissue Culture........32
Preparation of Media........32
Growth and Morphology........32
Sub Culturing Adherent Cells........32
Thawing Frozen Cells........32
Freezing Cells........32
1$100
   Cell Culture Contamination - A Looming Problem........33
Classification........33
Major Cell Culture Contaminants........33
Chemical Contamination........33
Types and Sources of Potential Chemical Contaminants........33
1$100
   Varied Sources of Chemical Contamination........34
Media and Components........34
Sera........34
1$100
   Water........35
Storage Vessels........35
Fluorescent Lights........35
Endotoxins........35
1$100
   Incubators........36
Biological Contamination........36
1$100
   Varied Sources of Biological Contamination........37
Mycoplasmas........37
Airborne Particles and Aerosols........37
1$100
   Cross Contamination by Other Cell Cultures........38
Consequences/Problems of Contamination........38
Controlling Cell Culture Contamination........38
1$100
   Measures Aimed at Reducing Contamination Problems........39
1$100
   Regulatory Environment........40
1$100
   StemCells Introduces GS1-R™........41
Kollodis BioSciences Introduces Cell-Culture Reagents........41
The Automation Partnership Launches Automated Cell-Culture........41
1$100
   Novartis Receives Approval to Release its New Vaccine........42
Invitrogen Introduces GIBCO® OpTmizer TM T-cell Expansion SFM........42
Novozymes Biopharma Rolls Out CellPrime in Partner ship with Millipore........42
1$100
   Invitrogen Launches Dynabeads® SSEA-4........43
Invitrogen Rolls Out KNOCKOUTTM SR XenoFree Media........43
Lonza Develops One-Step Program........43
Millipore Unveils ESGRO CompleteTM PLUS Medium........43
Millipore Introduces Hanging Millicell® Cell Culture Inserts........43
1$100
   SAFC Biosciences® Launches EX-CELLTM EBx®........44
SAFC Biosciences® Rolls Out EX-Fusion and CHO Library........44
Millipore Launches Epidermal Keratinocyte 3D Medium........44
1$100
   Invitrogen Rolls Out PD-Direct® Bioprocess Services........45
Millipore Unveils a New Variety of Primary Human Epithelial Cells........45
1$100
   BD Biosciences Introduces BD Analysis Kit........46
Thermo Fisher Scientific Rolls Out Thermo Clone........46
Lonza Introduces Poietics® Human Natural Killer (NK) Cells........46
1$100
   Millipore Launches New MillicoatTM Cultureware........47
Millipore Unveils High Content Analysis Kits........47
Millipore Rolls Out FlowCellect™........47
Invitrogen Introduces GIBCO® Bottles........47
1$100
   Invitrogen Unveils ST SFM, STEO and STEA Differentiation Kits........48
Thermo Fisher Scientific Launches NuncTM UpCellTM Surface........48
Millipore Releases New Primary Human Epithelial Cell Cultures........48
1$100
   Millipore Expands Stem Cell Tested Initiative........49
BD Biosciences Debuts BD FACSAria™ II System to Sort Cells........49
Invitrogen Introduces Specific SFM for the Mesenchymal Stem Cells........49
1$100
   StemCell Launches Cryopreservation Medium Free from Serum........50
Invitrogen Unveils SequalPrep™ System........50
Invitrogen Introduces Animal Source-Free Substrate........50
Invitrogen Introduces GIBCO® FoamAway™ Reagent........50
1$100
   Genetix Develops New CytoGenetix Reagents and Kits........51
1$100
   Thermo Fisher Launches NUNC In Vitro PDL Coated PETG Roller Bottles........52
Thermo Fisher Scientific Introduces HyClone AdvanceSTEM™ Cell Culture Product
  Line........52
Thermo Fisher Scientific Introduces New Medium to Culture PER.C6 Cell Line........52
Genetix Expands CloneMedia Semi-Solid Media Products........52
1$100
   Invitrogen Launches STEMPRO® EZPassage™ Tool........53
Sigma-Aldrich Introduces GenomePlex Tissue WGA Kit........53
Thermo Fisher Scientific Introduces Two New Versatile Media for HEK 293 Cell
  Line........53
SAFC Biosciences Launches LONG®R3IGF-I in Liquid Form........53
1$100
   Invitrogen and Novocell Introduce Media for hESC Growth........54
Invitrogen Releases New Culture System........54
Invitrogen Introduces New Line of Engineered Stem Cells........54
BD Biosciences Partners with StemCell Technologies........54
1$100
   Millipore Launches MEL Cell Lines........55
Irvine Scientific Expands Industrial Cell Culture Product Line........55
Biovest International Introduces Automated Cell Culture Device........55
1$100
   BD Biosciences Introduces BD FACSDiva™ 6.0 Software........56
Millipore Unveils Nylon Net Steriflip® Filter Unit........56
Lonza Expands Product-Portfolio with Serum Free Media........56
MediCult Unveils Flexible Culture Systems, BlastAssist® and EmbryoAssist™........56
1$100
   Millipore Introduces New Medium for Human Embryonic Stem Cell Research........57
Invitrogen Launches CytoGenie™ Cytometry Software Tool........57
Novozymes Releases New Cell Culture Components........57
The Automation Partnership Launches Advanced Plating Module........57
1$100
   Nikon Unveils BioStation CT........58
Corning Launches Innovative Cell Culture Solutions........58
GroPep Introduces New Assay Kit for Cell Culture Business........58
HyClone Introduces HyQ®CDM4MAb™ for Hybridoma Cell Lines........58
1$100
   INTEGRA Biosciences Adds Alarm Interface to CELLROLL and CELLSPIN Systems........59
Nikon Launches New Imaging and Tracking Systems for Cell Culture........59
Genetix Develops Cell Dispenser........59
SAFC Biosciences Introduces LONGTMR3IGF-I for Industrial Cell Culture........59
Biocrystal Presents Opticell........59
1$100
   TAP Unveils CompacT SelecT™........60
New Brunswick Scientific Augments New Products to Cell Culture Systems........60
Cell Culture Technologies Develops Fortified Production Media........60
1$100
   Akron Biotechnology Merges with AppliChem........61
ChanTest Takes Over Applied Cell Sciences........61
Millipore to Takeover Guava Technologies........61
1$100
   Millipore Acquires EpiTagTM Technology from Epitome Biosystems........62
MediCult’s BlastAssist® Culture Media Obtains FDA Approval........62
Capsant Signs Commercialization Agreement with VistaGen........62
1$100
   Millipore Inks Distribution Agreement with Solabia........63
Helix BioMedix Signs Production and Supply Agreement with Peptisyntha........63
BD Biosciences to Establish New Production Facility........63
1$100
   Lonza Group Takes Over amaxa........64
Millipore and Bayer Healthcare Sign Agreement........64
Applied Biosystems and Invitrogen Merge........64
SAFC BiosciencesTM and Celltrion Enter into Agreement........64
1$100
   Tata Chemicals to Acquire Stake in Joil........65
Sartorius Stedim Biotech Acquires Wave Biotech........65
Sigma-Aldrich and AlphaGenix Sign Distribution Agreement........65
Induce Biologics and Therapure Biopharma Enter into Collaboration........65
International Stem Cell and Millipore Sign Distribution Agreement........65
1$100
   Lonza Signs Agreement with Crucell........66
Eden Biodesign and Human Genome Sciences Sign Agreement........66
Becton, Dickinson to Establish New Production Facility........66
MedCell Bioscience Merges with NovaThera........66
1$100
   Covidien UK Holding Takes Over Tissue Science Laboratories........67
Invitrogen Establishes Dedicated Business Unit for Cell Therapy........67
Invitrogen Signs Deal to Acquire CellzDirect........67
Invitrogen Renews Agreement with Luminex Corporation........67
1$100
   BioTime Establishes Tissue Culture Facility........68
International Stem Cell Signs Agreement with ATCC........68
Millipore Signs Agreement with Solabia to Distribute Animal-Free Hydrolysates........68
1$100
   Affymetrix Acquires USB Corporation........69
SAFC to Expand Production Capacity of Viral Product........69
Lonza Signs Partnership Agreement with Sanofi to Produce Cell Culture Vaccine........69
1$100
   SAFC to Increase Fermentation Capabilities of High-Potency API........70
Biogen Offers Contract to Jacobs Engineering Group........70
New Brunswick Scientific Merges with Eppendorf Group........70
Vitrolife Extends Agreement with Cellartis........70
Sigma-Aldrich Inks Distribution Agreement with CellPath........70
1$100
   Lonza Acquires two Subsidiaries of Cambrex Bio-Businesses........71
Vikdas to Build Biotechnological Laboratory........71
Novartis to Invest in a New Cell Culture Plant in Singapore........71
Invitrogen Signs Agreement with Biocon........71
Lonza and Bio*One form Joint Venture for Mammalian Cell Culture Plant........71
1$100
   Thermo Fisher to Extend Manufacturing Operations........72
BD Biosciences Announces Treyburn Expansion Plans........72
BD Biosciences Collaborates with Roche to Advance Cell Signal Transduction
  Study........72
1$100
   Invitrogen and RXi Pharmaceuticals Enter into Collaboration........73
Millipore Forms a Strategic Alliance with Novozymes........73
Thermo Fisher Takes Over OptiCell Product Line........73
Invitrogen Collaborates with Cytori for Research on Adipose Stem Cell........73
1$100
   Thermo Fisher Partners with Cellular Engineering for Stem Cell Research........74
VWR Signs Agreement to Distribute Biovest’s Cell Culture Device........74
Genentech Constructs New Cell Culture Plant........74
Invitrogen Signs Deal with Wave Biotech to Offer Media-Filled Disposable
  Bioreactors........74
MediCult Purchases Humagen Fertility........74
1$100
   Millipore Acquires Serologicals........75
ReNeuron Inks Collaboration Agreement with CellSeed........75
Trans Valley Launches Tissue Cultured Variety of Mushrooms........75
HiMedia Laboratories Forges Distribution Deal with VWR International........75
Teva Signs Collaboration Agreement with Protalix Biotherapeutics........75
1$100
   SAFC-Biosciences Forms to Support Sigma-Aldrich........76
Invitrogen and Cellartis to Co-develop hESC Reporter Lines........76
CELLCA and Rentschler Join Forces for Unique High-Level Expression System........76
ArcDia Partners with Chip-Man Technologies........76
Chugai Pharmaceutical Receives License for Cell Line from Cambrex Bio Science
  Walkersville, Inc.........76
1$100
   Chemicon Inks Distribution Agreement with CELLnTEC........77
Chemicon Signs an Agreement with ReNeuron........77
Chemicon to Market Stem Cell Products of ASCC........77
SCS and Chemicon Introduce ESGRO Complete™ Product Range........77
1$100
   Serologicals Acquires Cytomyx Ltd........78
Millipore to Take Over Serologicals........78
CAT Opts SelectT™ for Higher Cell Culture Yields........78
1$100
   Affymetrix, Inc. (USA)........79
AMRESCO, Inc. (USA)........79
BD Biosciences (USA)........79
1$100
   Cell Culture Technologies, LLC (Switzerland)........80
Cell Essentials, Inc. (USA)........80
Irvine Scientific (USA)........80
Life Technologies Corporation (USA)........80
1$100
   Lonza Biologics Plc (UK)........81
Mediatech, Inc. (USA)........81
Millipore Corporation (USA)........81
Medi-Cult A/S (Denmark)........81
1$100
   MP Biomedicals (USA)........82
PerBio Science AB (Sweden)........82
PromoCell GmbH (Germany)........82
Sera Laboratories International (UK)........82
1$100
   Sigma-Aldrich Corporation (USA)........83
SAFC Biosciences (USA)........83
Vitrolife AB (Sweden)........83
1$100
   Table 1: World Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........841$350
   Table 2: World Historic Review for Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........851$350
   Table 3: World 11-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........861$350
   Cell/Tissue Culture Supplies Market by Product Segment........87
Table 4: World Recent Past, Current & Future Analysis for Media Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........87
1$350
   Table 5: World Historic Review for Media Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........881$350
   Table 6: World 11-Year Perspective for Media Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........891$350
   Table 7: World Recent Past, Current & Future Analysis for Sera Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........901$350
   Table 8: World Historic Review for Sera Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........911$350
   Table 9: World 11-Year Perspective for Sera Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart)........921$350
   Table 10: World Recent Past, Current & Future Analysis for Reagent Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........931$350
   Table 11: World Historic Review for Reagent Cell/Tissue Culture Supplies by Geographic Region – USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........941$350
   Table 12: World 11-Year Perspective for Reagent Cell/ Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for USA, Canada, Japan, Europe, Asia-Pacific (excluding Japan) & Latin America Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart)........95
1$350
   A. Market Analysis........96
Current & Future Analysis........96
Cell & Tissue Culture Market........96
A Brief Insight........96
1$100
   Market Trends........97
Trend Towards Serum-Free Media........97
Liquid and Powdered Media Account for Major Share........97
Table 13: Leading Players in the US Cell Culture Media Market (2008): Percentage Breakdown of Sales for - Sigma-Aldrich, Hyclone, Lonza Biologics, and Others (includes corresponding Graph/Chart)........97
1$350
   Fetal Bovine Serum - On A Decline........98
Rise in Cell Culture Equipment Demand Leads to Innovation........98
Market for Stem Cell Research........98
1$100
   End-Use Analysis........99
Table 14: US Market for Cell Culture Reagents by End Use - Academic, Industrial, and Non-Academic (2008) (includes corresponding Graph/Chart)........99
Factors Influencing the Market for Tissue and Cell Culture Media........99
Regulatory Controls........99
1$350
   Guidelines Governing Use of Cell/Tissue Culture Reagents........100
MSDS and Hazardous Information........100
Toxic Substances Control Act........100
1$100
   Export/Import Stats........101
Table 15: US Imports of Preparation Culture Media for the Development of Microorganisms and Plant/Human/Animal Cells (2009): Percentage Breakdown of Import Value by Country (includes corresponding Graph/Chart)........101

Table 16: US Exports of Preparation Culture Media for the Development of Microorganisms and Plant/Human/Animal Cells (2009): Percentage Breakdown of Export Value by Country (includes corresponding Graph/Chart)........101
1$350
   B. Market Analytics........102
Table 17: US Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........102
1$350
   Table 18: US Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1031$350
   Table 19: US 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........104
1$350
   A. Market Analysis........105
Current & Future Analysis........105
Biotechnology Industry........105
1$100
   B. Market Analytics........106
Table 20: Canadian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........106
1$350
   Table 21: Canadian Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........107

Table 22: Canadian 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........107
1$350
   A. Market Analysis........108
Current & Future Analysis........108
B. Market Analytics........108
Table 23: Japanese Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........108
1$350
   Table 24: Japanese Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........109

Table 25: Japanese 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........109
1$350
   A. Market Analysis........110
Current & Future Analysis........110
Market Overview........110
1$100
   B. Market Analytics........111
Table 26: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Geographic Region – France, Germany, UK, Italy & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........111
1$350
   Table 27: European Historic Review for Cell/Tissue Culture Supplies by Geographic Region – France, Germany, UK, Italy and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1121$350
   Table 28: European Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........1131$350
   Table 29: European Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1141$350
   Table 30: European 11-Year Perspective for Cell/Tissue Culture Supplies by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy & Rest of Europe Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart)........1151$350
   Table 31: European 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........116
1$350
   Market Analysis........117
Current & Future Analysis........117
Table 32: French Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........117
1$350
   Table 33: French Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........118

Table 34: French 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........118
1$350
   A. Market Analysis........119
Current & Future Analysis........119
Biotech Research Scenario........119
1$100
   Table 35: German Biotech Market (2009): Percentage Breakdown by Application Area – Environment, Human Health Care, Chemical industry, Food, Agriculture, Energy, and Others (includes corresponding Graph/Chart)........120
B. Market Analytics........120
Table 36: German Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........120
1$350
   Table 37: German Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........121

Table 38: German 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years2005, 2010 & 2015 (includes corresponding Graph/Chart)........121
1$350
   Market Analysis........122
Current & Future Analysis........122
Table 39: Italian Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........122
1$350
   Table 40: Italian Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........123

Table 41: Italian 11-Year Perspective for Cell/ Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........123
1$350
   A. Market Analysis........124
Current & Future Analysis........124
Biotechnology Industry – A Brief Insight........124
1$100
   Regulatory Issues........125
HFE Act Guidelines........125
The Ethical Issues........125
1$100
   B. Market Analytics........126
Table 42: UK Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........126
1$350
   Table 43: UK Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart)........127

Table 44: UK 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera, and Reagents Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........127
1$350
   A. Market Analysis........128
Current & Future Analysis........128
Scenario in other European Countries........128
1$100
   B. Market Analytics........129
Table 45: Rest of Europe Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........129
1$350
   Table 46: Rest of Europe Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1301$350
   Table 47: Rest of Europe 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........131
1$350
   A. Market Analysis........132
Current & Future Analysis........132
Rise of Cell Culture in Asia........132
India........132
Cell Culture Market Constituents........132
1$100
   China........133
Taiwan........133
Australia........133
1$100
   B. Market Analytics........134
Table 48: Asia-Pacific Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........134
1$350
   Table 49: Asia-Pacific Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1351$350
   Table 50: Asia-Pacific 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........136
1$350
   A. Market Analysis........137
Current & Future Analysis........137
Brazilian Biotech Industry........137
1$100
   B. Market Analytics........138
Table 51: Latin American Recent Past, Current & Future Analysis for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)........138
1$350
   Table 52: Latin American Historic Review for Cell/Tissue Culture Supplies by Product Segment – Media, Sera, and Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)........1391$350
   Table 53: Latin American 11-Year Perspective for Cell/Tissue Culture Supplies by Product Segment – Percentage Breakdown of Dollar Sales for Media, Sera and Reagent Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)........1401$350
  
Total Companies Profiled: 131 (including Divisions/Subsidiaries - 151)

Region/Country Players

The United States 89 Canada 4 Japan 2 Europe 45 France 2 Germany 10 The United Kingdom 19 Spain 1 Rest of Europe 13 Asia-Pacific (Excluding Japan) 7 Latin America 1 Middle east 3
Click here to request a full table of contents and more details on this project.